# INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study

> **NCT04346537** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 109 (actual)

## Conditions studied

- Bradycardia

## Interventions

- **DEVICE:** INGEVITY+™ Pace/Sense Lead

## Key facts

- **NCT ID:** NCT04346537
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-06
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2022-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04346537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04346537, "INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04346537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*